Ben Chappell has a background in Chemistry and Medicinal Chemistry, with experience working in various roles at companies such as Moa Technology, Infineum, AstraZeneca, and Pfizer. Ben also completed a PhD in Organic Chemistry at the University of Cambridge under the Gaunt Group. Currently, Ben holds the positions of Head of Synthetic Chemistry, Head of Compound Management, and Manager - Chemistry at Moa Technology.
April 1, 2024 - present
March, 2023
June, 2022